Redefining excellence in patient identification and delivery.
Sponsors do not buy sites.
They buy certainty.
Most SMOs compete on geography and scale. Panthera competes on certainty. The Pantheon is how.
These are not edge cases. They are the everyday realities of clinical research. The Pantheon was built to solve every one.
Slow identification of eligible cohorts means delayed first-patient-in dates and unpredictable enrolment timelines that threaten the entire programme.
Retention failures create missing data points, protocol deviations, and compromised statistical power that can undermine a submission.
Fragmented reporting across sites and countries leaves sponsors without the real-time visibility needed to make confident operational decisions.
Regulatory scrutiny is unforgiving. A single critical finding from an external body can derail years of investment and delay a product reaching patients.
Manual handoffs, inconsistent processes, and disconnected systems across territories introduce risk at every stage of the trial lifecycle.
Select a pillar to explore
Beneath all five pillars sit the two things that make every solution deliverable at scale.
An established network of approximately 40 experienced Principal Investigators, with deep therapeutic knowledge and the relationships to match the right study to the right site.
Digital identifies and predicts. Our people judge, select and deliver.
A proven, expanding multi-territory platform. OEC in Hungary acquired and integrated, with Bulgaria and the Netherlands in the pipeline.
Proven across borders, not just promised.
Other European SMOs compete on geography and scale: regional, often single-country led, integrating patchwork networks.
A proprietary 181,000-record patient intelligence database that took years to build and cannot be replicated.
Bespoke APIs engineered in-house deliver consistent data across sites, countries and continents. A patchwork of acquired systems cannot.
TrialTrack and the analytics layer are owned outright, not licensed. The advantage compounds with every study.
Zero critical findings from any external body. Live data, full transparency. A demonstrable record, not a claim.
A demonstrated acquisition and integration capability across borders. Built to expand, not just to operate.
A single integrated platform, bespoke to Panthera, delivered by an experienced PI network across every territory.
The Pantheon is not a feature list. It is a compounding platform that grows stronger with every study we run.
One integrated ecosystem. Five proven solutions. The confidence to commit to your programme and your patients.
Request a conversation